Skip to main content
Fig. 5 | BMC Cancer

Fig. 5

From: A predictive model for treatment response in patients with locally advanced esophageal squamous cell carcinoma after concurrent chemoradiotherapy: based on SUVmean and NLR

Fig. 5

This is a stage III ESCC patient with a SUVmean value at 4.99 and the NLR value at 0.80. According to the prediction model, the patient has Y-value of 0.86, which belongs to a good response patient. After receiving CCRT and sequential 2 cycles of chemotherapy, the repeated PET/CT examination showed that the primary esophageal lesion completely disappeared, and the treatment response was CR according to RECIST (version 1.1) evaluation standard

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us